- Home
- AMSC vs NEO Comparison
AMSC vs NEO Comparison
Compare AMSC & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMSC | NEO |
|---|---|---|
| Founded | 1987 | 2001 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AMSC | NEO |
|---|---|---|
| Price | $34.78 | $10.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $52.00 | $11.50 |
| AVG Volume (30 Days) | 1.4M | ★ 1.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $32.83 | $10.53 |
| Revenue Next Year | $24.80 | $9.25 |
| P/E Ratio | $11.83 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.98 | $4.72 |
| 52 Week High | $70.49 | $13.74 |
Technical Indicators
Market Signals| Indicator | AMSC | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 57.42 | 29.20 |
| Support Level | $31.05 | $9.28 |
| Resistance Level | $35.50 | $11.65 |
| Average True Range (ATR) | 3.36 | 0.68 |
| MACD | 0.73 | -0.15 |
| Stochastic Oscillator | 74.20 | 26.80 |
Price Performance
Historical ComparisonAbout AMSC American Superconductor Corporation
American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.